Changeflow GovPing Healthcare & Life Sciences Phase 3 Rectal Cancer Trial, Microsatellite Stable
Routine Notice Added Final

Phase 3 Rectal Cancer Trial, Microsatellite Stable

Email

Summary

NIH's ClinicalTrials.gov registry has registered a Phase 3 clinical trial (NCT07551479) evaluating treatment for microsatellite stable rectal cancer. The trial is indexed under Phase 3 status with a start date tracked in the registry. This entry provides standardized trial information including eligibility criteria, study design, and contact details for prospective participants and investigators.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 3 Trials by Start Date for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 21 changes logged to date.

What changed

This ClinicalTrials.gov entry registers a Phase 3 clinical trial (NCT07551479) focused on microsatellite stable rectal cancer. The registry entry provides structured metadata including trial phase, condition, and study identifiers for public access.

Healthcare providers, clinical investigators, and patients seeking oncology trial opportunities may use this registry entry to identify study eligibility and contact study coordinators. The trial is publicly listed and searchable via ClinicalTrials.gov's standard interface.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 3 Trials by Start Date

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Oncology research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 3 Trials by Start Date publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!